Kari J. Kurppa

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

Kari J. Kurppa, Yao Liu, Ciric To et al. · Cancer Cell · 2020 · 454 citations · Full text

Tumor Biology, Signaling Pathway, Cell Regulation +10

A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignancies

Steffen Boettcher, Peter G. Miller, Rohan Sharma et al. · Science · 2019 · 416 citations · Full text

High frequency of <scp>BRAF</scp><scp>V600E</scp> mutations in ameloblastoma

Kari J. Kurppa, Javier Catón, Peter R. Morgan et al. · The Journal of Pathology · 2013 · 296 citations · Full text

Mutant Braf, Erbb Receptors, Medicine +13

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Ciric To, Tyler S. Beyett, Jaebong Jang et al. · Nature Cancer · 2022 · 146 citations · Full text

Therapy-resistant Mutant Forms, Medicine, Pharmacology +9

ERBB4 Mutations that Disrupt the Neuregulin-ErbB4 Pathway Cause Amyotrophic Lateral Sclerosis Type 19

Yuji Takahashi, Y. Fukuda, Jun Yoshimura et al. · The American Journal of Human Genetics · 2013 · 143 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Erbb4 Mutations +6